Core Viewpoint - Rosen Law Firm is reminding investors who purchased SLM Corporation securities between July 25, 2025, and August 14, 2025, of the February 17, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought SLM securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must file with the Court by February 17, 2026 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked highly in securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. Group 3: Case Allegations - The lawsuit alleges that during the Class Period, SLM made false and misleading statements regarding its financial health, specifically concerning early-stage delinquencies and the effectiveness of its loss mitigation programs [5]. - It is claimed that these misrepresentations led to a materially false impression of SLM's business and operations, resulting in investor damages when the truth was revealed [5].

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation for allegedly misleading investors regarding its business operations and sales performance during the specified class period [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired Integer securities from July 25, 2024, to October 22, 2025 [1][2]. - Investors have until February 9, 2026, to seek appointment as lead plaintiff representative [2]. Group 2: Allegations Against the Company - The complaint claims that Integer made misleading statements and omitted critical information about its business, including overstating its market position and failing to disclose a decline in sales of electrophysiology devices [3]. - Following the announcement of reduced sales guidance on October 23, 2025, Integer's stock price dropped by $35.22 per share, representing a decline of over 32% in one day [3].

San Diego, California--(Newsfile Corp. - January 5, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of StubHub Holdings, Inc. (NYSE: STUB) common stock pursuant and/or traceable to StubHub's offering documents issued in connection with StubHub's September 17, 2025 initial public offering ("IPO"), have until Friday, January 23, 2026 to seek appointment as lead plaintiff of the StubHub class action lawsuit. Captioned Salabaj v. StubHub Holdings, Inc., No. 25-cv-09776 (S.D.N.Y. ...

Core Viewpoint - The SLM Corporation, also known as Sallie Mae, is facing a class action lawsuit for allegedly making misleading statements regarding its financial stability and delinquency rates during a specified class period [1][3]. Group 1: Class Action Lawsuit Details - Investors in SLM securities from July 25, 2025, to August 14, 2025, can seek appointment as lead plaintiff by February 17, 2026 [1]. - The lawsuit, titled Zappia v. SLM Corporation, accuses SLM and its executives of violating the Securities Exchange Act of 1934 [1]. - The allegations include that SLM experienced a significant increase in early-stage delinquencies, which was not disclosed to investors [3]. Group 2: Financial Impact and Misleading Statements - A report from investment bank TD Cowen indicated that July 2025 delinquencies rose by 49 basis points month-over-month, contradicting SLM's earlier assurances about delinquency rates [4]. - Following the release of this report, SLM's stock price fell by approximately 8% [4]. - The lawsuit claims that SLM overstated the effectiveness of its loss mitigation and loan modification programs [3]. Group 3: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who invested in SLM securities during the class period to seek lead plaintiff status [5]. - The lead plaintiff represents the interests of all class members and can choose a law firm for litigation [5]. - An investor's potential recovery is not contingent upon being the lead plaintiff [5]. Group 4: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation [6]. - The firm has secured over $2.5 billion for investors in securities-related class action cases in 2024, ranking first in monetary relief for investors [6]. - Robbins Geller has a significant history of obtaining large recoveries in securities class action cases, including the largest recovery of $7.2 billion in the Enron case [6].

SAN FRANCISCO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is alerting investors in Primo Brands Corporation (NYSE: PRMB) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action lawsuit is January 12, 2026.   The firm urges investors who suffered substantial losses to contact our firm now. The lawsuit seeks to recover investor losses sustained after the disclosure of an allegedly concealed severe, operational crisi ...

Core Viewpoint - A class action lawsuit has been filed against Stride, Inc. for allegedly misleading investors regarding its operations and financial performance during the specified Class Period [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased Stride securities from October 22, 2024, to October 28, 2025 [1][2]. - Allegations include inflated enrollment numbers, staffing cuts below statutory limits, non-compliance with requirements, and concealment of enrollment losses [3]. Group 2: Impact on Share Price - The truth about Stride's operations was revealed on September 14, 2025, when a school district sued the company for fraud [4]. - On October 28, 2025, Stride announced that "poor customer experience" led to higher withdrawal rates and fewer enrollments, causing a significant decline in share price [4].

Core Viewpoint - A class action lawsuit has been filed against Telix Pharmaceuticals Ltd. on behalf of investors who purchased its securities during the specified Class Period, alleging misleading statements regarding the company's business and operations [1][3]. Group 1: Lawsuit Details - The lawsuit is initiated by Berger Montague PC, representing investors who bought Telix securities from February 21, 2025, to August 28, 2025 [1][2]. - Investors have until January 9, 2026, to seek appointment as lead plaintiff representatives [2]. Group 2: Allegations Against Telix - Defendants are accused of making false or misleading statements and failing to disclose that Telix overstated its progress with prostate cancer therapeutic candidates [3]. - The company allegedly exaggerated the quality of its supply chain and partners, leading to misleading statements about its business and prospects [3]. - The complaint claims that when the true state of Telix's business was revealed, investors experienced significant financial losses [3].

Core Viewpoint - Purcell & Lefkowitz LLP is investigating OS Therapies Incorporated to determine if the company's directors breached their fiduciary duties related to recent corporate actions [1]. Group 1 - The investigation is being conducted on behalf of OS Therapies's shareholders [1]. - The law firm specializes in representing shareholders who are victims of securities fraud and breaches of fiduciary duty [3]. - Shareholders interested in their rights and options can contact the firm for more information [2].

Core Viewpoint - The Freeport-McMoRan Inc. is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, primarily related to safety issues at its Grasberg mine in Indonesia, which resulted in significant operational and financial repercussions for the company [1][3]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Reed v. Freeport-McMoRan Inc., and it involves purchasers of Freeport-McMoRan securities from February 15, 2022, to September 24, 2025 [1]. - The lawsuit alleges that Freeport-McMoRan and certain executives made false or misleading statements regarding safety measures at the Grasberg Block Cave mine, which heightened risks for workers [3]. - Specific incidents leading to the lawsuit include a significant flow of wet material at the mine on September 9, 2025, which restricted evacuation routes and led to a nearly 6% drop in stock price [4]. Group 2: Incident Impact and Financial Consequences - On September 24, 2025, Freeport-McMoRan reported two fatalities and the ongoing search for five missing team members, resulting in a projected 35% decrease in production for 2026 compared to pre-incident estimates, causing the stock price to fall nearly 17% [5]. - Following a Bloomberg article on September 25, 2025, discussing the potential strain on relations with the Indonesian government due to halted production, the stock price fell more than 6% [6]. Group 3: Legal Process and Firm Background - The Private Securities Litigation Reform Act of 1995 allows investors who purchased Freeport-McMoRan securities during the class period to seek appointment as lead plaintiff, representing the interests of the class [7]. - Robbins Geller Rudman & Dowd LLP, the law firm handling the case, is recognized as a leading firm in securities fraud litigation, having recovered over $2.5 billion for investors in 2024 alone [8].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Central District of California, captioned Hern v. Alexandria Real Estate Equities, Inc., et al., No. 2:25-cv-11319 [3]. - Investors have until January 26, 2026, to request to be appointed to lead the case [3]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Alexandria Real Estate securities [3]. Group 2: Company Background - Alexandria Real Estate is a real estate investment trust focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Group 3: Financial Performance and Stock Impact - Alexandria Real Estate reported lower-than-expected results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 on October 28, 2025 [6]. - The company announced a real estate impairment charge of $323.9 million, with $206 million attributed to its Long Island City property, which was deemed not suitable for life science scaling [5][6]. - Additional impairment charges may be recognized in Q4 2025, ranging from $0 to $685 million [6].